Dallas Fort Worth Injury Lawyer Blog

Earlier this year, motions for federal centralization of pretrial proceedings in the Stryker Rejuvenate and ABG II modular-neck hip implant products lawsuits were presented for consideration by the United States Judicial Panel on Multidistrict Litigation, JPML.

The injury cases in this litigation involve alleged defects in Stryker’s Rejuvenate and ABG II modular-neck hip implant products. According to the Plaintiffs’ allegations, the performance of these products is suspect, particularly the hip replacement devices’ tendency to cause fretting and corrosion at the modular-neck junction and fail early.

151 Stryker Rejuvenate and ABG II Pending Federal Lawsuits

Two years ago the FDA announced that there was no evidence that transvaginal mesh provides any benefits when compared to traditional surgery. Unfortunately according to medical studies, transvaginal mesh procedure and device implantation has a risk of serious complications.

The FDA issued warnings about the safety of surgical mesh for treatment of pelvic organ prolapse and female stress urinary incontinence in July 2011. The FDA received 3,000 reports of vaginal mesh complaints between January 2008 and December 2010, involving injuries where the mesh eroded through the vagina, damaged the bowel, bladder and other critical injuries.

FDA Orders More Studies

According to a recent medical study, the side effects of Lipitor and other statin drugs may increase the risk of diabetes. The Canadian study published in the British Medical Journal, demonstrated that Lipitor users are 22% more likely to be diagnosed with diabetes.

The study found that Lipitor was associated with the greatest risk of diabetes. Other cholesterol lowering drugs including Crestor, was associated with an 18% increased risk and Zocor, was associated with a 10% increased risk of diabetes.

Lipitor Diabetes Lawsuits

As a Byetta/Januvia/Victoza Thyroid and Pancreatic Cancer attorney and a Texas medical doctor, I am providing this litigation update regarding Incretic Mimetics lawsuits. A 23 year old woman has filed a product liability lawsuit against Amylin Pharmaceuticals and Eli Lilly & Co., claiming that she developed thyroid cancer from side effects of Byetta. Byetta is a newer type of diabetes drug that plaintiffs claim causes pancreatic cancer and thyroid cancer.

The complaint was filed by Elizabeth Childress on May 9, in the U.S. District Court for the Southern District of California. Childress, alleges that she was diagnosed with thyroid cancer in 2011, after using Byetta for several years.

According to Childress, Amylin and Eli Lilly have known about the link between Byetta and thyroid cancer, yet failed to provide adequate warnings or issue a Byetta recall to withdraw the diabetes drug from the market.

In May, an Illinois man filed a $100 million defective medical product liability Stryker hip lawsuit in the U.S. District Court for the Northern District of Illinois. According to the plaintiff, he received an ABG II implant during hip replacement surgery. The plaintiff alleges the ABG II system was defective and it caused him to sustain permanent injuries. Plaintiff claims that Howmedica Osteonics, and Stryker Orthopaedics was negligent and failed to warn patients about the risks associated with the hip replacement system.

What is ABG II Hip Replacement System?

The Stryker ABG II system is a metal and metal hip implant composed of interchangeable chrome cobalt neck and titanium stem components. The FDA allowed Stryker Orthopaedics to market and distribute the hip replacement system in 2009.

According to a recent medical study, the side effects of Lipitor and other statin drugs may increase the risk of diabetes. The Canadian study published in the British Medical Journal, demonstrated that Lipitor users are 22% more likely to be diagnosed with diabetes.

The study found that Lipitor was associated with the greatest risk of diabetes. Other cholesterol lowering drugs including Crestor, was associated with an 18% increased risk and Zocor, was associated with a 10% increased risk of diabetes.

Lipitor Diabetes Lawsuits